Skip to main content
. 2020 Aug 2;12(8):e9518. doi: 10.7759/cureus.9518

Table 1. Demographic Data.

Mean Age at Diagnosis Standard Deviation
51.77 17.57
Histopathology Type Frequency Percentage
  Serous 12 92.31
  Poorly differentiated 1 7.69
Procedure Type Frequency Percentage
  Optimal debulking 7 53.85
  Suboptimal debulking 2 15.38
  Other 3 23.08
Chemotherapy Type Frequency Percentage
  Taxane and carboplatin 4 30.77
  Carboplatin single agent 3 23.08
  Ribosomal doxorubicin and carboplatin 2 15.38
  Taxane 1 7.69
  Other 1 7.69
  No chemotherapy 2 15.38